Variant report
Variant | esv1818076 |
---|---|
Chromosome Location | chr8:6828858-6880504 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:48)
- CpG islands (count:428)
- Chromatin interactive region (count:2)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:48 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr8:6829807-6830004 | K562 | blood: | n/a | n/a |
2 | BACH1 | chr8:6829927-6829940 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CEBPB | chr8:6872820-6873018 | HepG2 | liver: | n/a | chr8:6872838-6872849 chr8:6872837-6872848 |
4 | CTCF | chr8:6832055-6832125 | GM13976 | blood: | n/a | n/a |
5 | CTCF | chr8:6875862-6875906 | Kidney_OC | kidney: | n/a | n/a |
6 | CTCF | chr8:6829420-6829509 | LNCaP | prostate: | n/a | n/a |
7 | CTCF | chr8:6829829-6829883 | LNCaP | prostate: | n/a | n/a |
8 | CTCF | chr8:6876641-6876732 | GM13976 | blood: | n/a | n/a |
9 | CTCF | chr8:6850725-6850800 | Lung_OC | lung: | n/a | n/a |
10 | CTCF | chr8:6863352-6863389 | GM13977 | blood: | n/a | n/a |
11 | CTCF | chr8:6829826-6829954 | LNCaP | prostate: | n/a | n/a |
12 | CTCF | chr8:6868755-6868819 | GM13976 | blood: | n/a | n/a |
13 | CTCF | chr8:6870668-6870718 | Lung_OC | lung: | n/a | n/a |
14 | CTCF | chr8:6841333-6841432 | GM10248 | blood: | n/a | n/a |
15 | CTCF | chr8:6830206-6830256 | Kidney_OC | kidney: | n/a | n/a |
16 | CTCF | chr8:6833327-6833368 | Kidney_OC | kidney: | n/a | n/a |
17 | CTCF | chr8:6830796-6830848 | Lung_OC | lung: | n/a | n/a |
18 | FOS | chr8:6829914-6829972 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | GABPA | chr8:6878604-6878734 | Hela-S3 | cervix: | n/a | n/a |
20 | JUN | chr8:6829481-6830053 | K562 | blood: | n/a | n/a |
21 | JUN | chr8:6829918-6830101 | K562 | blood: | n/a | n/a |
22 | JUND | chr8:6829868-6829984 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | JUND | chr8:6829930-6830012 | HepG2 | liver: | n/a | n/a |
24 | JUND | chr8:6829764-6829956 | H1-hESC | embryonic stem cell: | n/a | n/a |
25 | JUND | chr8:6829760-6830100 | K562 | blood: | n/a | n/a |
26 | KAP1 | chr8:6829741-6830106 | HEK293 | kidney: | n/a | n/a |
27 | KAP1 | chr8:6829739-6830136 | U2OS | brain: | n/a | n/a |
28 | MAFF | chr8:6829846-6829893 | HepG2 | liver: | n/a | n/a |
29 | MAFK | chr8:6829943-6829957 | Hela-S3 | cervix: | n/a | n/a |
30 | MAFK | chr8:6829763-6829959 | H1-hESC | embryonic stem cell: | n/a | chr8:6829896-6829907 chr8:6829896-6829907 chr8:6829891-6829906 |
31 | MAFK | chr8:6829787-6829987 | HepG2 | liver: | n/a | chr8:6829896-6829907 chr8:6829896-6829907 chr8:6829891-6829906 |
32 | MAFK | chr8:6829930-6829935 | HepG2 | liver: | n/a | n/a |
33 | POLR2A | chr8:6838321-6838399 | Gliobla | brain: | n/a | n/a |
34 | POLR2A | chr8:6857571-6857648 | Gliobla | brain: | n/a | n/a |
35 | POLR2A | chr8:6845727-6845752 | MCF-7 | breast: | n/a | n/a |
36 | POLR2A | chr8:6845770-6845778 | MCF-7 | breast: | n/a | n/a |
37 | SETDB1 | chr8:6829763-6830144 | U2OS | brain: | n/a | n/a |
38 | SPI1 | chr8:6837542-6837676 | K562 | blood: | n/a | chr8:6837626-6837639 |
39 | SPI1 | chr8:6875751-6875885 | K562 | blood: | n/a | chr8:6875835-6875848 |
40 | SPI1 | chr8:6866274-6866450 | K562 | blood: | n/a | n/a |
41 | SPI1 | chr8:6856652-6856786 | K562 | blood: | n/a | chr8:6856736-6856749 |
42 | SPI1 | chr8:6847171-6847347 | K562 | blood: | n/a | n/a |
43 | SPI1 | chr8:6841978-6842199 | GM12891 | blood: | n/a | chr8:6842120-6842133 |
44 | SPI1 | chr8:6861083-6861304 | GM12891 | blood: | n/a | chr8:6861225-6861238 |
45 | TEAD4 | chr8:6843230-6843570 | H1-hESC | embryonic stem cell: | n/a | n/a |
46 | TEAD4 | chr8:6862289-6862645 | H1-hESC | embryonic stem cell: | n/a | n/a |
47 | TEAD4 | chr8:6862289-6862677 | H1-hESC | embryonic stem cell: | n/a | n/a |
48 | TEAD4 | chr8:6843178-6843665 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:6876155-6876205 | CMK | blood: | n/a |
2 | chr8:6876155-6876205 | CMK | blood: | n/a |
3 | chr8:6837932-6837982 | PrEC | prostate: | n/a |
4 | chr8:6875661-6875711 | IMR90 | lung: | fetal |
5 | chr8:6837932-6837982 | HAEpiC | amniotic membrane: | n/a |
6 | chr8:6838024-6838074 | T-47D | breast: | n/a |
7 | chr8:6873754-6873804 | AoSMC | blood vessel: | n/a |
8 | chr8:6838024-6838074 | A549 | lung: | n/a |
9 | chr8:6837932-6837982 | SK-N-MC | brain: | n/a |
10 | chr8:6873754-6873804 | Caco-2 | colon: | n/a |
11 | chr8:6876155-6876205 | H1-hESC | embryonic stem cell: | embryo |
12 | chr8:6837932-6837982 | GM19239 | blood: | n/a |
13 | chr8:6837932-6837982 | H1-hESC | embryonic stem cell: | embryo |
14 | chr8:6876695-6876745 | SAEC | small airway: | n/a |
15 | chr8:6875661-6875711 | MCF-7 | breast: | n/a |
16 | chr8:6838024-6838074 | Hepatocyte | liver: | n/a |
17 | chr8:6875661-6875711 | LNCaP | prostate: | n/a |
18 | chr8:6876781-6876831 | AoSMC | blood vessel: | n/a |
19 | chr8:6837932-6837982 | GM12891 | blood: | n/a |
20 | chr8:6875661-6875711 | HUVEC | blood vessel: | n/a |
21 | chr8:6875661-6875711 | SK-N-MC | brain: | n/a |
22 | chr8:6876781-6876831 | HUVEC | blood vessel: | n/a |
23 | chr8:6876155-6876205 | Hepatocyte | liver: | n/a |
24 | chr8:6837932-6837982 | AG09319 | gingival: | n/a |
25 | chr8:6837932-6837982 | AG09309 | skin: | n/a |
26 | chr8:6838024-6838074 | HPAEpiC | pulmonary alveolar: | n/a |
27 | chr8:6876695-6876745 | HCF | heart: | n/a |
28 | chr8:6876695-6876745 | PFSK-1 | brain: | n/a |
29 | chr8:6875661-6875711 | A549 | lung: | n/a |
30 | chr8:6873754-6873804 | IMR90 | lung: | fetal |
31 | chr8:6837932-6837982 | HNPCEpiC | eye: | n/a |
32 | chr8:6875661-6875711 | HL-60 | blood: | n/a |
33 | chr8:6837932-6837982 | A549 | lung: | n/a |
34 | chr8:6837932-6837982 | CMK | blood: | n/a |
35 | chr8:6838024-6838074 | GM06990 | blood: | n/a |
36 | chr8:6838024-6838074 | SKMC | muscle: | n/a |
37 | chr8:6837932-6837982 | HEEpiC | esophagus: | n/a |
38 | chr8:6876155-6876205 | AG09309 | skin: | n/a |
39 | chr8:6873754-6873804 | NT2-D1 | testis: | n/a |
40 | chr8:6838024-6838074 | AG10803 | skin: | n/a |
41 | chr8:6876695-6876745 | SKMC | muscle: | n/a |
42 | chr8:6837932-6837982 | PFSK-1 | brain: | n/a |
43 | chr8:6876155-6876205 | HEK293 | kidney: | embryo |
44 | chr8:6837932-6837982 | BJ | skin: | n/a |
45 | chr8:6838024-6838074 | AG04449 | skin: | fetal |
46 | chr8:6875661-6875711 | HCPEpiC | choroid plexus: | n/a |
47 | chr8:6876155-6876205 | NB4 | blood: | n/a |
48 | chr8:6838024-6838074 | NT2-D1 | testis: | n/a |
49 | chr8:6876695-6876745 | HepG2 | liver: | n/a |
50 | chr8:6876781-6876831 | GM12878 | blood: | n/a |
(count:2 , 50 per page) page:
1
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DEFA1B-1 | chr8:6845622-6845808 | NONHSAT124804 |
2 | lnc-DEFA1B-1 | chr8:6844700-6844945 | NONHSAT124804 |
3 | lnc-DEFA1B-1 | chr8:6847181-6847243 | NONHSAT124804 |
No data |
No data |
Variant related genes | Relation type |
---|---|
DEFA3 | TF binding region |
DEFT1P | TF binding region |
DEFA1B | TF binding region |
DEFT1P2 | TF binding region |
DEFA10P | TF binding region |
DEFA1 | TF binding region |
DEFA3 | CpG island |
DEFT1P | CpG island |
DEFA1B | CpG island |
DEFT1P2 | CpG island |
DEFA10P | CpG island |
DEFA1 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73661318 | chr8:6828885-6828886 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs34914251 | chr8:6828890-6828891 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs549119083 | chr8:6828904-6828905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565726897 | chr8:6828909-6828910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534860613 | chr8:6828921-6828922 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558061987 | chr8:6828924-6828925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs71525781 | chr8:6828933-6828934 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2978915 | chr8:6828964-6828965 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs537005526 | chr8:6828979-6828980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556685828 | chr8:6828984-6828985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs367666114 | chr8:6829042-6829043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113758444 | chr8:6829049-6829050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573651603 | chr8:6829061-6829062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs111388785 | chr8:6829064-6829065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs111524060 | chr8:6829069-6829070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143983769 | chr8:6829078-6829079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2738113 | chr8:6829085-6829086 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
18 | rs573076937 | chr8:6829118-6829119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545240643 | chr8:6829119-6829120 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565225789 | chr8:6829126-6829127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2738110 | chr8:6829137-6829138 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs144917777 | chr8:6829139-6829140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561143019 | chr8:6829140-6829141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554212108 | chr8:6829142-6829143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530144442 | chr8:6829170-6829171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546757306 | chr8:6829203-6829204 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149001552 | chr8:6829206-6829207 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373775525 | chr8:6829210-6829211 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs377589550 | chr8:6829232-6829233 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528286546 | chr8:6829233-6829234 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs111909730 | chr8:6829236-6829237 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571520519 | chr8:6829243-6829244 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2738107 | chr8:6829255-6829256 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550515424 | chr8:6829269-6829270 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567134304 | chr8:6829273-6829274 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536271364 | chr8:6829274-6829275 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2977817 | chr8:6829301-6829302 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552786717 | chr8:6829319-6829320 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192201762 | chr8:6829335-6829336 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs71525782 | chr8:6829349-6829350 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2978914 | chr8:6829357-6829358 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs71525783 | chr8:6829365-6829366 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375238775 | chr8:6829483-6829484 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs572640168 | chr8:6829503-6829504 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs538804038 | chr8:6829530-6829531 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs60281374 | chr8:6829561-6829562 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs58972774 | chr8:6829564-6829565 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs201631444 | chr8:6829565-6829566 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs558750484 | chr8:6829578-6829579 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs368497651 | chr8:6829579-6829580 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Breast cancer | 17142309 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Autism | 21865298 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Behcet''s disease | 22219625 | CNVD |
Crohn''s disease | 21701837 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6794600-6829200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:6822800-6830000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr8:6824800-6829200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr8:6828600-6829600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr8:6829200-6829400 | Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr8:6829200-6829400 | Enhancers | Right Ventricle | heart |
7 | chr8:6829200-6830200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr8:6829600-6830000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr8:6829600-6830000 | Enhancers | Fetal Brain Male | brain |
10 | chr8:6829600-6830200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
11 | chr8:6829800-6830000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr8:6830000-6833000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
13 | chr8:6831000-6831200 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
14 | chr8:6833000-6833600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
15 | chr8:6833600-6837800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
16 | chr8:6837800-6838200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
17 | chr8:6838200-6840600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
18 | chr8:6840600-6841800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
19 | chr8:6856800-6857400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
20 | chr8:6863200-6866800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
21 | chr8:6867000-6871800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
22 | chr8:6871800-6873000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
23 | chr8:6872400-6872600 | Enhancers | Primary hematopoietic stem cells | blood |
24 | chr8:6873000-6873400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
25 | chr8:6873400-6884600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
26 | chr8:6879800-6881200 | Enhancers | Dnd41 | blood |